Mfar Clinical Research
Mfar Clinical Research is recorded as a service provider in 12 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 12 of 12 trials · Latest update first
RINGQUEST: Exploring Understudied Genitourinary Tumors with Sacituzumab Tirumotecan; a Single-arm, Basket, Phase II Study.
Sponsor Alianza Multidisciplinar Para La Investigacion De Los Tumores Genitourinarios Guard
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
A randomized phase III, global, multicentre, open label clinical trial comparing Venetoclax Azacitidine and Quizartinib versus Venetoclax and Azacitidine in newly diagnosed acute myeloid leukemia patients ineligible for standard induction chemotherapy
Sponsor Fundacion PETHEMA
- Start (EU)
- Latest update
- Estimated end
Selective Bladder-Sparing Trial with Sasanlimab as Maintenance Treatment Based On Clinical Response To Neoadjuvant Treatment In Molecularly Categorized Muscle Invasive Bladder Cancer Patients
Sponsor Fundacion De investigacion De Hm Hospitales
- Start (EU)
- Latest update
- Estimated end
- Not reported
Exploratory clinical trial to assess safety, tolerability efficacy and pharmacokinetics of CEB-01 PLGA membrane in participants with pancreatic cancer
Sponsor Cebiotex S.L.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Quantitative Unified Assessment of Novel Triplet therapy and Unconventional Maintenance with Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer: A Phase II Pilot Trial
Sponsor Alianza Multidisciplinar Para La Investigacion De Los Tumores Genitourinarios Guard
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Phase II, single arm, multicentre clinical trial to evaluate the activity of encorafenib plus binimetinib followed by Cemiplimab And Fianlimab in patients with BRAF mutated melanoma and symptomatic brain metastases.
Sponsor Grupo Espanol Multidisciplinar De Melanoma
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase II, Open-Label, Multicenter, Non-Randomized Study Of The Efficacy And Safety Of Enfortumab Vedotin In Combination With Pembrolizumab Previously Treated Advanced Melanoma
Sponsor Grupo Espanol Multidisciplinar De Melanoma
- Start (EU)
- Latest update
- Estimated end
- Not reported
Randomized Interval Assessment trial of Lu177-Dotatate every 8 versus every 16 weeks in slowly progressive G1-2 advanced midgut neuroendocrine tumors (NETs) to Lower TOxicity.
Sponsor Grupo Espanol De Tumores Neuroendocrinos
- Start (EU)
- Latest update
- Estimated end
- Not reported
First-in-paediatrics, open label, exploratory, externally controlled clinical trial to evaluate safety, efficacy and pharmacokinetics of 7-ethyl-10-hydroxy-camptothecin (SN-38) formulated as a biocompatible polymeric nanofiber membrane (CEB-01) for treatment, in addition to standard of care, of paediatric patients from birth to less than 18 years of age with a locally resectable tumours in comparison to standard of care.
Sponsor Cebiotex S.L.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Phase II, Open-Label Study of preliminary efficacy of Sitravatinib in Combination with Tislelizumab in Patients with Metastatic Uveal Melanoma with liver metastases.
Sponsor Grupo Espanol Multidisciplinar De Melanoma
- Start (EU)
- Latest update
- Estimated end
- Not reported
An open label, multicenter, phase II study of belantamab mafodotin in combination with VRd for the treatment of newly diagnosed transplant eligible multiple myeloma patients
Sponsor Fundacion Pethema
- Start (EU)
- Latest update
- Estimated end
- Not reported
A Phase II, Multicenter, Randomized Study of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5FU in Subjects with Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (ERBIOTAX)
Sponsor Grupo Espanol De Tratamiento De Tumores De Cabeza Y Cuello
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Mfar Clinical Research?
The 2026-10-09 snapshot links Mfar Clinical Research to 12 distinct CTIS trials. Recorded services include Project management, Clinical monitoring, Safety reporting & pharmacovigilance, Data management, among 11 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Mfar Clinical Research?
The most frequently recorded therapeutic areas are Haematological Malignancies, Solid Tumor Oncology, Urology. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Mfar Clinical Research conducted?
The linked trials record locations in 2 countries, including Spain, France. These are trial locations, not confirmed office locations or countries where Mfar Clinical Research delivered services.
What can this page tell me about Mfar Clinical Research's trial experience?
Browse 12 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Mfar Clinical Research. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Mfar Clinical Research S.L.